In addition, stem cell markers, such as, SOX2 and Nestin, were also upregulated in GBM-RICCS compared with the control group (Figure 3C), suggesting that GBM-RICCS exhibits stem-like characters in glioma cells. This evidence concerns the gene NES and central nervous system cancer.